Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Inventory Average (2019 - 2025)

BioNexus Gene Lab's Inventory Average history spans 7 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Inventory Average fell 8.22% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $1.1 million, down 8.22%, while the annual FY2024 figure was $1.3 million, 19.42% up from the prior year.
  • Inventory Average for Q3 2025 was $1.1 million at BioNexus Gene Lab, down from $1.2 million in the prior quarter.
  • Across five years, Inventory Average topped out at $1.6 million in Q3 2021 and bottomed at $938721.5 in Q1 2023.
  • The 5-year median for Inventory Average is $1.2 million (2024), against an average of $1.3 million.
  • The largest annual shift saw Inventory Average surged 17784.94% in 2021 before it tumbled 40.79% in 2023.
  • A 5-year view of Inventory Average shows it stood at $1.5 million in 2021, then plummeted by 31.1% to $1.0 million in 2022, then rose by 8.29% to $1.1 million in 2023, then rose by 23.69% to $1.4 million in 2024, then dropped by 19.97% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for BGLC's Inventory Average are $1.1 million (Q3 2025), $1.2 million (Q2 2025), and $1.3 million (Q1 2025).